Fundraising FoxSynolo Therapeutics
1 known investors
Find your way into Synolo Therapeutics
Sign up to see every warm intro you have to Synolo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synolo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Synolo Therapeutics develops conditionally-active immunotherapies for treating cancer, using a proprietary discovery platform to build a pipeline of oncology drug candidates. It aims to offer treatments that are more effective and safer than the current standard of care.
Investors · 1
Frequently asked questions
- What does Synolo Therapeutics do?
- Synolo Therapeutics develops conditionally-active immunotherapies for treating cancer, using a proprietary discovery platform to build a pipeline of oncology drug candidates. It aims to offer treatments that are more effective and safer than the current standard of care.
- Who are Synolo Therapeutics's investors?
- Synolo Therapeutics's investors include RA Capital.